|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07F 9/24 | |
| A61K 31/675 | |||
| C07F 9/655 |
| (11) | Patento numeris | 3390413 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16876437.1 |
| Europos patento paraiškos padavimo data | 2016-12-12 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-10-24 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-08-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2016/066075 |
| Data | 2016-12-12 |
| (87) | Numeris | WO 2017/106069 |
| Data | 2017-06-22 |
| (30) | Numeris | Data | Šalis |
| 201562267505 P | 2015-12-15 | US |
| (72) |
FU, Wenlang, US
GUO, Zhiqiang, US
QI, Ning, US
RAHEEM, Izzat, T., US
VACHAL, Petr, US
WANG, Ming, US
SCHREIER, John, D., US
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
|
| (54) | ANTIVIRAL OXIME PHOSPHORAMIDE COMPOUNDS |
| ANTIVIRAL OXIME PHOSPHORAMIDE COMPOUNDS |